Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AARSD1,Alanyl-tRNA editing protein Aarsd1,22532,81,1.50 [1.08-2.08],0.016401717296617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22636,82,0.61 [0.40-0.94],0.0253533538147679
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19160,71,1.67 [1.14-2.45],0.0082534898722113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22705,82,1.88 [1.21-2.93],0.0053047024779559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHSP,Alpha-hemoglobin-stabilizing protein,22606,79,1.46 [1.17-1.82],0.0006786709883465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKT2,RAC-beta serine/threonine-protein kinase,19678,72,0.83 [0.69-0.99],0.0358852327197701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH1A1,Retinal dehydrogenase 1,22641,79,1.74 [1.29-2.34],0.0003143242385608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALPP,"Alkaline phosphatase, placental type",22532,81,1.22 [1.01-1.48],0.0378607942077706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMOT,Angiomotin,19296,70,2.09 [1.27-3.43],0.0035028267633282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMPD3,AMP deaminase 3,19668,71,1.43 [1.07-1.92],0.0151356225908182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL4,Angiopoietin-related protein 4,22700,82,1.73 [1.12-2.66],0.0133491536688434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANKRA2,Ankyrin repeat family A protein 2,19016,71,0.60 [0.38-0.94],0.0268622708896368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARG1,Arginase-1,22541,82,1.49 [1.04-2.13],0.0302885445631846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP45,Rho GTPase-activating protein 45,19296,70,0.75 [0.56-1.00],0.0462215089786443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATG4A,Cysteine protease ATG4A,22124,81,1.43 [1.06-1.93],0.0190378097376847
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN10,Ataxin-10,22073,79,0.74 [0.58-0.95],0.0189454534717758
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B4GALT1,"Beta-1,4-galactosyltransferase 1",22739,82,2.45 [1.22-4.89],0.0115180638057468
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2,Apoptosis regulator Bcl-2,19608,71,0.50 [0.28-0.87],0.0137666810462665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22597,82,0.54 [0.38-0.76],0.0003925559480538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLVRB,Flavin reductase,22641,79,1.52 [1.19-1.96],0.0009197318436646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMP6,Bone morphogenetic protein 6,22196,80,0.65 [0.43-0.99],0.0464668209892721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRK1,Protein BRICK1,22073,79,0.58 [0.36-0.93],0.0244458546195781
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTN1A1,Butyrophilin subfamily 1 member A1,19567,71,1.51 [1.15-1.97],0.0029040845861208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19296,70,0.55 [0.33-0.91],0.018758813538393
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C2,Complement C2,22661,82,2.64 [1.01-6.91],0.0480347305761155
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C9orf40,Uncharacterized protein C9orf40,19608,71,1.43 [1.12-1.84],0.0046635054418927
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA1,Carbonic anhydrase 1,22103,81,1.47 [1.09-1.98],0.0123420986245688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA13,Carbonic anhydrase 13,22398,82,0.82 [0.69-0.98],0.0304644147234394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA2,Carbonic anhydrase 2,22565,79,1.46 [1.13-1.88],0.0038527883561449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA3,Carbonic anhydrase 3,22866,81,1.43 [1.07-1.91],0.0151622923030506
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22124,81,0.58 [0.35-0.96],0.0326886084517688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CARHSP1,Calcium-regulated heat-stable protein 1,22073,79,1.55 [1.11-2.16],0.0102733609682416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP7,Caspase-7,19668,71,0.73 [0.55-0.96],0.0222651349223109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAT,Catalase,19406,68,1.72 [1.20-2.45],0.003063772658596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL27,C-C motif chemokine 27,22636,82,1.54 [1.11-2.15],0.0103092923699697
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN5,CCN family member 5,22641,79,1.63 [1.01-2.65],0.0472316566467887
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH3,Cadherin-3,22833,80,1.70 [1.03-2.82],0.0392046562677097
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR1,Cadherin-related family member 1,22073,79,1.50 [1.06-2.13],0.0218378550849515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR2,Cadherin-related family member 2,22532,81,1.31 [1.01-1.69],0.0404479189146989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEMIP2,Cell surface hyaluronidase,19160,71,1.75 [1.30-2.35],0.0002182837751979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP164,Centrosomal protein of 164 kDa,22210,82,1.25 [1.00-1.56],0.0472348030881386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CETN2,Centrin-2,22073,79,0.70 [0.51-0.97],0.0299673529719148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,19711,71,1.34 [1.03-1.74],0.0315813661435133
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGN,Cingulin,19160,69,1.47 [1.00-2.15],0.049849614950449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC6A,C-type lectin domain family 6 member A,22124,81,1.58 [1.07-2.34],0.0201617269757297
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CMC1,COX assembly mitochondrial protein homolog,19709,73,0.74 [0.58-0.96],0.0235084932506243
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNPY4,Protein canopy homolog 4,22532,81,0.75 [0.58-0.97],0.030985711545957
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COPE,Coatomer subunit epsilon,22073,79,1.50 [1.14-1.97],0.0041496694874122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPVL,Probable serine carboxypeptidase CPVL,22809,83,0.64 [0.42-0.98],0.0379275755071621
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRELD2,Protein disulfide isomerase CRELD2,22700,82,0.62 [0.42-0.91],0.0158398959791566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYBB1,Beta-crystallin B1,19709,73,0.64 [0.44-0.92],0.0154883423697787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYM,Ketimine reductase mu-crystallin,19101,70,1.27 [1.02-1.58],0.035073422106006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22486,81,0.60 [0.43-0.84],0.0033090147488125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSH1,Chorionic somatomammotropin hormone 1,19711,71,1.48 [1.14-1.91],0.0031106458851876
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSNK1D,Casein kinase I isoform delta,19160,71,0.65 [0.43-0.99],0.0455218701771125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSO,Cathepsin O,22885,83,2.13 [1.18-3.85],0.0118011566166973
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL13,C-X-C motif chemokine 13,22833,80,1.39 [1.14-1.70],0.0009949328525199
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL5,C-X-C motif chemokine 5,22563,82,0.83 [0.71-0.99],0.033673926536707
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYB5R2,NADH-cytochrome b5 reductase 2,19365,70,0.63 [0.40-0.97],0.0376210302144857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22705,82,2.24 [1.28-3.93],0.0048011043689876
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDI2,Protein DDI1 homolog 2,19296,70,1.45 [1.11-1.89],0.0060438279226151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB103A_DEFB103B,Beta-defensin 103,19008,71,1.49 [1.10-2.02],0.0097165760979995
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DGCR6,Protein DGCR6,19101,70,1.52 [1.17-1.97],0.0018307384720974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,19668,71,0.52 [0.29-0.93],0.0285699990254196
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNM1,Dynamin-1,19608,71,0.76 [0.63-0.92],0.0049655640899436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNM3,Dynamin-3,19678,72,0.49 [0.30-0.81],0.004899786600345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,22705,82,1.48 [1.04-2.10],0.0309254752652557
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECHS1,"Enoyl-CoA hydratase, mitochondrial",19209,70,0.77 [0.60-0.98],0.0344702464934078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EHBP1,EH domain-binding protein 1,19709,73,0.72 [0.53-0.99],0.045187838221156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EHD3,EH domain-containing protein 3,19209,70,0.83 [0.68-1.00],0.0472210463021994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP4,"Fatty acid-binding protein, adipocyte",22905,81,0.60 [0.39-0.92],0.0197779097378328
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM20A,Pseudokinase FAM20A,19709,73,0.42 [0.19-0.94],0.0352549189246102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL5,Fc receptor-like protein 5,22641,79,1.87 [1.32-2.66],0.0004410401951817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOSB,Protein fosB,22073,79,1.51 [1.10-2.07],0.0117726391833408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOXO1,Forkhead box protein O1,22597,82,0.79 [0.62-1.00],0.049679569477724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FST,Follistatin,22700,82,1.44 [1.00-2.07],0.0488929169764261
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22532,81,2.29 [1.17-4.46],0.0150695762609518
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19209,70,0.72 [0.52-0.99],0.0403121592912119
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRA2,GDNF family receptor alpha-2,22532,81,0.36 [0.16-0.83],0.0167250512294271
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP5,Platelet glycoprotein V,19296,70,0.55 [0.30-1.00],0.04952560963984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR15L,Protein GPR15L,19608,71,0.65 [0.45-0.93],0.0178430084285011
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRIK2,"Glutamate receptor ionotropic, kainate 2",19678,72,1.57 [1.07-2.29],0.0197089457820018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19101,70,1.39 [1.08-1.79],0.0094045762931498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSR,"Glutathione reductase, mitochondrial",19592,71,0.46 [0.26-0.82],0.0082794629828795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GTPBP2,GTP-binding protein 2,19160,69,0.71 [0.52-0.96],0.0248266696723092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",22765,83,1.35 [1.05-1.72],0.0170482959735652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAVCR1,Hepatitis A virus cellular receptor 1,22804,83,1.41 [1.03-1.92],0.0306291181755081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HBQ1,Hemoglobin subunit theta-1,22837,83,1.50 [1.13-2.00],0.0055917817746842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDAC9,Histone deacetylase 9,19101,70,0.59 [0.35-0.99],0.0441253593066366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMBS,Porphobilinogen deaminase,22837,83,1.70 [1.11-2.61],0.0140736359679994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HPSE,Heparanase,19427,72,0.73 [0.58-0.92],0.0069007017735902
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,22837,83,2.05 [1.40-2.99],0.000232019189143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19668,71,1.46 [1.04-2.05],0.0285752255731345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF3,Immunoglobulin superfamily member 3,22532,81,1.67 [1.06-2.65],0.0284182322977315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18R1,Interleukin-18 receptor 1,22885,83,1.79 [1.01-3.16],0.0462491320052175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL21R,Interleukin-21 receptor,19160,71,1.43 [1.10-1.85],0.00751360703302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL7R,Interleukin-7 receptor subunit alpha,22641,79,0.69 [0.48-0.99],0.0427549348507341
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSL4,Early placenta insulin-like peptide,19602,71,1.36 [1.05-1.77],0.0185291401636245
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,21764,78,0.47 [0.27-0.82],0.0071429101399454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISM2,Isthmin-2,19705,73,1.71 [1.30-2.26],0.0001537658192666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB1BP2,Integrin beta-1-binding protein 2,22232,80,0.83 [0.69-0.98],0.0292347018269546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KAZN,Kazrin,19608,71,0.79 [0.64-0.99],0.0372927344270757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA1549L,UPF0606 protein KIAA1549L,19329,70,2.60 [1.60-4.24],0.0001216004664677
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT6C,"Keratin, type II cytoskeletal 6C",19109,70,1.51 [1.03-2.20],0.0351319385512299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEO1,RNA polymerase-associated protein LEO1,19678,72,1.52 [1.04-2.23],0.0317390861990097
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LETM1,Mitochondrial proton/calcium exchanger protein,19678,72,0.61 [0.37-0.98],0.0425308337117461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,22664,82,1.51 [1.13-2.01],0.0055442456622282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19160,69,1.38 [1.00-1.91],0.048585954854046
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LXN,Latexin,22383,81,1.39 [1.08-1.79],0.0096189336085983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19678,72,0.66 [0.43-0.99],0.0440110181534308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTDH,Protein LYRIC,19160,71,0.77 [0.59-1.00],0.0479880896751077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTIF3,"Translation initiation factor IF-3, mitochondrial",19608,71,0.74 [0.56-0.97],0.0265602495748045
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTSS2,Protein MTSS 2,19602,71,0.73 [0.57-0.92],0.0073206426863531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYDGF,Myeloid-derived growth factor,19709,73,0.77 [0.61-0.97],0.0236202933722429
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL4,Myosin light chain 4,19209,70,1.55 [1.13-2.12],0.0063180532829511
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAAA,N-acylethanolamine-hydrolyzing acid amidase,22380,80,1.60 [1.19-2.16],0.0017470461085414
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19608,71,0.75 [0.58-0.98],0.0318219459922319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",19608,71,0.78 [0.63-0.98],0.0343272790742426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NME1,Nucleoside diphosphate kinase A,19160,71,2.43 [1.06-5.61],0.0369381947767533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOMO1,Nodal modulator 1,22641,79,2.77 [1.48-5.19],0.0013870106913504
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRGN,Neurogranin,19711,71,0.76 [0.59-0.98],0.0316529749614676
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTproBNP,N-terminal prohormone of brain natriuretic peptide,22636,82,1.23 [1.01-1.48],0.0348351993748984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ORM1,Alpha-1-acid glycoprotein 1,19669,72,0.30 [0.09-0.98],0.0467303928974296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OTUD7B,OTU domain-containing protein 7B,19678,72,0.68 [0.47-0.99],0.0459488287287588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PADI4,Protein-arginine deiminase type-4,22043,79,1.24 [1.01-1.52],0.0357548772432615
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PBK,Lymphokine-activated killer T-cell-originated protein kinase,19016,71,3.27 [1.90-5.63],1.918605039276231e-05
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDHB15,Protocadherin beta-15,19602,71,1.72 [1.10-2.70],0.0181215835729404
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19296,70,0.80 [0.65-0.98],0.0352895930564937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA4,Protein disulfide-isomerase A4,19705,73,0.63 [0.42-0.94],0.0219606966132575
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PER3,Period circadian protein homolog 3,19160,71,0.73 [0.58-0.90],0.0034202123237183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGF,Placenta growth factor,22885,83,1.96 [1.25-3.07],0.0032053762468896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19478,71,0.50 [0.25-0.99],0.0478955154525659
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHACTR2,Phosphatase and actin regulator 2,19678,72,0.80 [0.66-0.98],0.0302640253137818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHLDB2,Pleckstrin homology-like domain family B member 2,19016,71,1.30 [1.11-1.52],0.0012270230003356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKLR,Pyruvate kinase PKLR,22666,82,1.43 [1.11-1.86],0.0064678136391575
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G15,Phospholipase A2 group XV,22705,82,2.23 [1.08-4.61],0.0309331902991372
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLAU,Urokinase-type plasminogen activator,22641,79,1.72 [1.18-2.52],0.0051723419617019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLB1,"Phospholipase B1, membrane-associated",19668,71,0.67 [0.47-0.95],0.0251839547833473
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLEKHO1,Pleckstrin homology domain-containing family O member 1,19668,71,0.70 [0.49-0.99],0.0455337252358821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXDC2,Plexin domain-containing protein 2,19668,71,0.40 [0.16-0.99],0.0480394084954884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXNB2,Plexin-B2,22804,81,2.38 [1.06-5.33],0.0352295963971869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNLIPRP1,Inactive pancreatic lipase-related protein 1,19668,71,1.44 [1.08-1.93],0.0132505154262266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPM1F,Protein phosphatase 1F,19709,73,0.61 [0.39-0.94],0.0261362301857956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPME1,Protein phosphatase methylesterase 1,22532,81,1.44 [1.05-1.97],0.0224595756251241
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,19602,71,0.71 [0.53-0.95],0.0194410713276113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19329,70,0.64 [0.42-0.98],0.0393081488630766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP3R1,Calcineurin subunit B type 1,22486,81,0.60 [0.37-0.98],0.0410519501697049
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX2,Peroxiredoxin-2,19371,70,1.55 [1.13-2.14],0.00660751249032
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRR4,Proline-rich protein 4,19158,70,1.45 [1.07-1.96],0.0154779621591546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMD9,26S proteasome non-ATPase regulatory subunit 9,22532,81,1.53 [1.14-2.06],0.0044830574628014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMG3,Proteasome assembly chaperone 3,22597,82,1.52 [1.08-2.16],0.0178905932145325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMG4,Proteasome assembly chaperone 4,19160,71,1.43 [1.02-1.99],0.0375050918539067
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18605,66,0.80 [0.65-0.99],0.0368911913960001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,QPCT,Glutaminyl-peptide cyclotransferase,22676,81,2.13 [1.07-4.24],0.0318895036307762
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB11FIP3,Rab11 family-interacting protein 3,19709,73,0.78 [0.63-0.96],0.0164158510463048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBKS,Ribokinase,22095,79,1.67 [1.16-2.40],0.0054151079698411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG4,Regenerating islet-derived protein 4,22672,82,0.54 [0.35-0.83],0.0052076760936536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGCC,Regulator of cell cycle RGCC,19678,72,0.73 [0.54-0.98],0.0387082623582492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF31,E3 ubiquitin-protein ligase RNF31,19160,71,0.44 [0.20-0.99],0.0478792669268685
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF5,E3 ubiquitin-protein ligase RNF5,19209,70,0.71 [0.53-0.95],0.0226316642657796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SARG,Specifically androgen-regulated gene protein,19634,73,0.81 [0.66-0.99],0.0385488809732362
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCG2,Secretogranin-2,22723,82,0.49 [0.26-0.91],0.0252314820681588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA7A,Semaphorin-7A,22837,81,2.56 [1.51-4.34],0.0004936724457165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFTPA2,Pulmonary surfactant-associated protein A2,22124,81,1.79 [1.32-2.43],0.0001641536101027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3GLB2,Endophilin-B2,19668,71,1.44 [1.04-1.98],0.026212253201265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC8,Sialic acid-binding Ig-like lectin 8,19209,70,0.57 [0.34-0.96],0.0338140696177962
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD3,Mothers against decapentaplegic homolog 3,19602,71,0.56 [0.35-0.92],0.0208688241560189
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPD1,Sphingomyelin phosphodiesterase,22720,80,1.53 [1.03-2.27],0.0340885953341677
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAP23,Synaptosomal-associated protein 23,22636,82,0.80 [0.65-0.99],0.0404106685581434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNCG,Gamma-synuclein,22486,81,0.74 [0.55-0.98],0.0337954345589474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINT1,Kunitz-type protease inhibitor 1,22577,79,2.04 [1.05-3.95],0.0352928064811711
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPP1,Osteopontin,22866,81,0.66 [0.45-0.99],0.0451084333520512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRY2,Protein sprouty homolog 2,22210,82,0.78 [0.62-0.98],0.0293708408924641
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19101,70,1.70 [1.00-2.88],0.0498321199828143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TACC3,Transforming acidic coiled-coil-containing protein 3,22532,81,0.84 [0.71-0.99],0.0401775636953215
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TADA3,Transcriptional adapter 3,19602,71,0.44 [0.24-0.80],0.0072858631102502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBC1D17,TBC1 domain family member 17,22073,79,1.52 [1.11-2.08],0.009471995431426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFF3,Trefoil factor 3,22593,81,1.50 [1.14-1.96],0.0034578502176218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFPI2,Tissue factor pathway inhibitor 2,22633,82,1.44 [1.03-2.00],0.0326407915009764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBI,Transforming growth factor-beta-induced protein ig-h3,22476,82,2.21 [1.10-4.46],0.0260300239246604
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGM2,Protein-glutamine gamma-glutamyltransferase 2,22606,82,1.53 [1.19-1.95],0.0007366053774618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,19709,73,0.51 [0.27-0.95],0.0344397083334969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TINAGL1,Tubulointerstitial nephritis antigen-like,22561,82,2.44 [1.05-5.66],0.0380089134212112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22210,82,0.53 [0.30-0.93],0.0259547423975406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22672,82,2.86 [1.78-4.61],1.5718498564249358e-05
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF13,Tumor necrosis factor ligand superfamily member 13,22739,82,0.39 [0.19-0.83],0.01427103824874
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,19709,73,0.72 [0.52-0.98],0.0379681710808428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM40,E3 ubiquitin ligase TRIM40,19160,69,0.67 [0.48-0.95],0.0224038801483475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TWF2,Twinfilin-2,19705,73,0.72 [0.55-0.95],0.0189342853663531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBAC1,Ubiquitin-associated domain-containing protein 1,22532,81,1.77 [1.04-3.02],0.0368926722306794
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VASP,Vasodilator-stimulated phosphoprotein,19711,71,0.70 [0.51-0.97],0.033897394111268
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VGF,Neurosecretory protein VGF,19678,72,0.44 [0.21-0.94],0.0341664506087711
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSNL1,Visinin-like protein 1,19668,71,0.43 [0.22-0.83],0.0113333303497136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VTCN1,V-set domain-containing T-cell activation inhibitor 1,22124,81,1.81 [1.06-3.08],0.0303238925572173
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWA5A,von Willebrand factor A domain-containing protein 5A,19016,71,0.63 [0.40-0.98],0.0394261524927684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YOD1,Ubiquitin thioesterase OTU1,19109,70,1.55 [1.11-2.18],0.0103328125406376
